Cargando...
Explaining The Cost Of Biotech Therapies
Health plans and employers are strategizing about how to finance biotech therapies, which can run five and six figures per patient per year. The challenge to manufacturers is to communicate the value of their products now – before someone defines it for them.
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioCommunications LLC
2004
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3555164/ https://ncbi.nlm.nih.gov/pubmed/23372497 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|